Early research (Phase 1)Looking for participantsNCT06660420
What this trial is testing
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Who this might be right for
Phase 1Recurrent MelanomaRefractory Melanoma
M.D. Anderson Cancer Center 39